baber/WOPTO huggingface dataset:
Patent NZ-242616-A (NZ)
Title: Reduction products of rapamycin, production process and medicaments
Inventor: CAUFIELD CRAIG EUGENE
IPC: A61P37/06
Filed: 1992-05-05
Abstract: Products of formula (I) obtained from the chemical reduction of one or more of the ketone groups at positions 15, 27 and 33 of Rapamycin with diisobutylaluminum hydride or sodium triacetoxyborohydride have been shown to have pharmacological properties which would make them useful in the treatment of transplantation rejection, autoimmune diseases, diseases of inflammation and Candida albicans infections. <CHEM> u
Patent NZ-249166-A (NZ)
Title: Decontaminating rooms of a dwelling using an atomiser containing an essential oil based product
Inventor: BLANC MICHEL
IPC: A61L2/22
Filed: 1993-02-05
Abstract: PCT No. PCT/FR93/00121 Sec. 371 Date Aug. 10, 1994 Sec. 102(e) Date Aug. 10, 1994 PCT Filed Feb. 5, 1993 PCT Pub. No. WO93/15774 PCT Pub. Date Aug. 19, 1993A process for decontamination and detoxification of a room wherein an atomizer is used to diffuse a product containing essential oils as a mist. The outer openings of the room to be decontaminated and detoxified are closed and the product is diffused as a true aerosol from the center of the room. After the diffusion is stopped, the mist is allowed to decontaminate and detoxify room and the room is then aired.
Patent NZ-260532-A (NZ)
Title: Preparing aqueous dispersion of polymeric latex (having at least one dihydrogen phosphate group) and titanium dioxide, by allowing the latex particles to adsorb onto the pigment particles
Inventor: EMMONS WILLIAM DAVID
IPC: C09D7/62
Filed: 1994-05-16
Abstract: Coating compositions including stable composite latex-pigment particles are prepared by dispersing titanium dioxide pigment particles in a dispersion of selected polymeric latex particles which have at least one dihydrogen phosphate functional group. The selected polymeric latex particles adsorb on to the titanium dioxide particles. Dibasic phosphate is then provided to the mixture to stop adsorption and stabilize the composite particles. The coating composition gives a coating with improved hiding.
Patent NZ-316647-A (NZ)
Title: Antisecretory recombinant peptides regulating fluid transport and inflammatory reactions and uses thereof
Inventor: LONNROTH IVAR
IPC: A23K1/165
Filed: 1996-08-23
Abstract: A new recombinant protein called Antisecretory Factor (rAF) and homologues and peptide fragments thereof are described. The protein and the homologues and fragments thereof are useful for normalizing pathological fluid transport and/or inflammatory reactions in animals including humans. Antibodics against AF or homologues or fragments thereof are described. Nucleic acids coding for the protein or for homologues or fragments thereof are also described as well as vectors and hosts comprising the nucleic acids. The rAF and homologues and fragments thereof could be used for immunodetection, as feed additive for growing animals and as antidiarrheal and drugs against diseases involving edema, dehydration and/or inflammation.
Patent NZ-331161-A (NZ)
Title: Synthetic HIV genes encoding envelope (env) proteins
Inventor: SHIVER JOHN W
IPC: A61P31/00
Filed: 1997-02-18
Abstract: The specification describes synthetic DNA molecules encoding HIV genes and modifications of HIV genes are provided. The codons of the synthetic molecules use codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity.
Patent NZ-336679-A (NZ)
Title: Roller and spot liquid applicator having a cylindrical applicator surface
Inventor: MOORE REX WARREN
IPC: B05C17/035
Filed: 1999-07-09
Abstract: An applicator assembly (10) has a liquid applicator (14) which is rotatably mounted. Preferably the liquid applicator (14) has a substantially cylindrical surface for applying the liquid. A spacer (30) at one end extends past the cylindrical applicator surface but the other end of the cylindrical applicator surface is substantially free so that the applicator can also be used for dabbing the liquid. The applicator assembly (10) may further comprise an elongate stem (12) of sufficient length to enable an upright user to hold the applicator assembly (10) at one end and ground it at the other end. A guard (60) extends over and proximate to the cylindrical surface. In the upright operative position of the applicator assembly (10), the guard extends beyond the applicator surface in the forward direction. At the other end of the applicator assembly (10) to the stem (12), a funnel (16) is provided to assist with pouring liquid into the stem (12). The liquid applicator (14) may be supplied with liquid from an auxiliary roller (25) formed by coring out the center of the liquid applicator (14) during its manufacture. Moreover an invention resides in an air valve (112) comprised of a thermoplastic rubber compound which is resilient and pliable. A path (114) for air extends through the valve and is defined in part by two spaced opposed surfaces (116) which are inclined towards each other and which meet to lie flat against each other for a distance along the path (114). An invention also resides in a flow control tap (80) of a composition in the range of 15 to 35 percent w/w and polypropylene in the range of 65 to 85 percent w/w, the composition being exclusive of polyethylene.
Patent NZ-502815-A (NZ)
Title: Hyaluronic acid gel formed from a freeze/thawing process of an acidified hyaluronic acid aqueous solution
Inventor: OSHIMA KAZUHIRO
IPC: A61L27/20
Filed: 1998-08-07
Abstract: The hyaluronic acid gel keeps its shape for at least one day in a neutral aqueous solution at 25 C. The gel is obtained by freezing and then thawing a hyaluronic acid aqueous solution at pH 3.5 or lower.
Patent NZ-508259-A (NZ)
Title: Mousse composition
Inventor: ABRAM ALBERT ZORKO
IPC: A61K47/14
Filed: 1999-09-08
Abstract: A pharmaceutical aerosol foam composition comprising a pharmaceutically active agent, an occlusive agent, an aqueous solvent and organic cosolvent; whereby the active agent is solubilised in the composition but insoluble in both water and the occlusive agent.
Patent NZ-508652-A (NZ)
Title: Syntheses of a variety of lamellarin compounds and analogues
Inventor: BANWELL MARTIN GERHARDT
IPC: A61K31/4745
Filed: 1999-06-25
Abstract: A  method for the preparation of compounds of  formula (II)  is described, comprising the step of an intramolecular cyclisation  of  compounds  of  formula  (I),  wherein   the substituents are defined herein.
Patent NZ-509915-A (NZ)
Title: Method and system for processing seismic signals including a single type of wavefield extraction
Inventor: GIDLOW MAURICE
IPC: G01V1/36
Filed: 1999-08-23
Abstract: Seismic data resulting from a reflected seismic wave is received at a multi-component receiver (300). A mask trace (305) is generated as a function of the seismic data received, and a single type of seismic signals from the seismic data received at the multi-component receiver is identified and extracted utilizing the mask trace. Extracting the single type of seismic signals (310) includes multiplying the seismic data received at one component (340) of the multi-component receiver with the mask trace wherein the single type of seismic signals represents seismic waves received at the one component of the multi-component receiver.
Patent NZ-510765-A (NZ)
Title: Method for the rapid screening of analytes
Inventor: ROELANT CHRISTIAAN HUBERT SIMO
IPC: B01L3/00
Filed: 1998-09-08
Abstract: A method for the rapid screening of analytes, such  as potential  drug candidates, comprises the steps of  applying a  plurality  of analytes to be screened onto  one  or  more solid   support(s)  (61)  such  that  the  analytes   remain isolated  from one another; contacting said analyte-carrying solid  support(s) (61) with targets provided in a semi-solid or  liquid  medium, whereby said analytes are released  from the  solid  support(s)  (61) to the targets;  and  measuring analyte-target  interactions. This  method  allows  for  the manipulation    of    thousands   of   different    analytes simultaneously.  When the analyte is applied  to  the  solid support  (61)  it  can diffuse thereon so as  to  produce  a concentration gradient and serial dilution of analyte  if  a dose  response  curve for a candidate drug is required.  The method described can be readily automated.
Patent NZ-512678-A (NZ)
Title: Particles in flow cytometer irradiated by annular inspection beam and beam optics producing an annular disc inspection beam
Inventor: SHARPE JOHNATHAN
IPC: G02B27/10
Filed: 1998-02-02
Abstract: An instrument for the analysis of particles, particularly sperm, flowing from a source 79 along a flow path 80 through an inspection zone 84, includes an optical arrangement including a source 71 of electromagnetic radiation that is directed via the prism 74 and the reflector 78 of the arrangement to converge the radiation as a substantially coplanar, radially symmetric radiation beam towards the inspection zone.  The reflectors 78 and 104 collect light scattered by the particles into a beam 103 that is analyzed to determine the particle properties.
Patent NZ-515162-A (NZ)
Title: Method for the inactivation of cryptosporidium parvum and giardia cysts using ultraviolet light
Inventor: BOLTON JAMES R
IPC: A61L2/10
Filed: 2000-04-27
Abstract: Methods for the inactivation of Cryptosporidium oocysts and similar organisms or Giardia cysts and similar organisms comprising irradiating the water containing said Cryptosporidium and organisms or said Giardia and organisms with ultraviolet light in doses sufficient to negatively affect replication thereof wherein the ultraviolet dose when irradiating water containing said Cryptosporidium and organisms is in the range of about 1 mJ/cm2 up to but below about 10 mJ/cm2 and when irradiating water containing said Giardia and organisms is in the range of about 1 mJ/cm2 to about 175 mJ/cm2.
Patent NZ-516973-A (NZ)
Title: Control for an automatic washer with spray pretreatment
Inventor: WHAH KENNETH N
IPC: D06F39/00
Filed: 2002-02-01
Abstract: This control relates a control for an automatic washer incorporating a spray pretreatment or stain care cycle. In order to manage the occurrence of the condition of suds lock, the state of the washing machine related to the suds lock condition during spray pretreatment is determined by one or more of a number of methods. With this information concerning the state of the spray pretreatment process, the occurrence of suds lock can be ascertained and the cycle can be controlled accordingly to minimize negative effects resulting from a prolonged suds lock condition. Additionally, with certain information related to the occurrence of suds lock, steps can be taken during the spray pretreatment portion of the cycle to avoid the condition of suds lock altogether. Using the same primary process for measuring suds lock, load size can also be ascertained. Information about load size can be used to control the wash cycle.
Patent NZ-520039-A (NZ)
Title: Authenticating articles with up-converting material using two different wavelengths and measuring emission from material
Inventor: EGGER PHILIPP
IPC: G06K19/06
Filed: 2000-12-21
Abstract: A advanced product security system comprising at least one up-converting material as a security marking and at least one authenticating equipment, in particular a reader is disclosed, wherein the authenticating equipment comprises at least one first source of electromagnetic radiation of at least one first preselected wavelength and at least one second source of at least one second preselected wavelength which are different from each other; the radiation of the first and of the second wavelength are selected such as to cause the up-converting material upon combined radiation with the first and second wavelength to release an emission spectrum; the electromagnetic emission spectrum of the up-converting material comprises radiation of at least one wavelength which is specific for the return of at least one electron from an energy level to which the electron is raised by the combined radiation of at least the first and the second wavelength.
Patent NZ-521290-A (NZ)
Title: Novel piperazine derivatives
Inventor: BLUMBERG LAURA COOK
IPC: C07D521/00
Filed: 2001-03-14
Abstract: Disclosed are compounds of formula I, wherein; X is C(O), C(S) or CH2, Y is CH2 orCHR8, Z is oxygen, NR9 or CR11R12, and the remaining substituents are defined herein. The compounds are used for the manufacture of medicaments for the treatment of diseases mediated by the inhibition of chemokine binding to receptor CCR1.
Patent NZ-526281-A (NZ)
Title: Sanitary filtration plant with helical filter elements
Inventor: LARSEN KNUD VERNER
IPC: B01D63/12
Filed: 2001-12-19
Abstract: A sanitary filtration plant has an oblong, tubular pressure vessel 1, which includes one or more helical filter elements 2 to 4. Each such element ha a spiral-wound filter member 5 to 7 and a central tube 8 to 10. At the end being the outlet end, each helical filter element 2 to 4 having a supporting means 19 to 21 formed as a wheel with a hub 22, spokes and a rim 31 and centrally a transition means 35. The transition means is adapted to ensure a sealing flow connection between abutting ends of central tubes 8 to 10. In addition, each supporting means 18 to 21 has plane sides for abutment against the ends of the filter members of the respective helical filter elements 19 to 21, and along the external periphery they comprise a sealing means 39 for a sealing abutment against the inner side of the pressure vessel 1. The plane side being the downstream face of each supporting means 19 to 21 during ordinary operation of the plant is provided with a plurality of recesses 41, 43 and 44. Each recess extends between an opening between the spokes and the external periphery of the rim 31.
Patent NZ-527323-A (NZ)
Title: Sustained-release suspension of ceftiofur hydrochloride
Inventor: KIM YONG-SIK
IPC: A61K9/10
Filed: 2002-02-04
Abstract: Disclosed is a sustained release suspension composition consisting of ceftiofur or pharmaceutically acceptable salts thereof, tocopherol or a derivative thereof, and a biocompatible oil wherein the tocopherol or the derivative therof is selected from the group consisting of alpha-tocopherol, beta-tocopherol, gamma-tocopherol, delta-tocopherol, alpha-tocopherol succinate and tocopherol acetate, and mixtures thereof with the proviso that compositions in the form of emulsions rather than suspensions are disclaimed.
Patent NZ-527621-A (NZ)
Title: Web playlist system, method, and computer program
Inventor: BLENNERHASSETT JOHN STEWART
IPC: G06F17/00
Filed: 2003-08-15
Abstract: An internet browser comprises: a plurality of network addresses maintained in computer memory, the network addresses representing a sequence; at least one browser window configured to display to a user at least one web page identified by one of the network addresses; and a playlist engine configured to retrieve, in the absence of user selection successive network addresses from the sequence and, on user selection, to retrieve the user selected network address(es) from the sequence and further configured to display, in the browser window, web pages corresponding to the network addresses.
Patent NZ-529460-A (NZ)
Title: Novel heteroaryl derivatives with an effect on 5-HT1a receptors and dopamine D4 receptors and their use in the treatment of psychotic disorders
Inventor: ROTTLANDER MARIO
IPC: A61P9/10
Filed: 2002-06-27
Abstract: A compound represented by the general formula (I) is described wherein X represents 0, NR16, S or CR4R5; Y is -CR6R7, -CR6R7-CR8R9- or CO-CR6R7; or X and Y together form a group -CR4=CR5- or -CR4=CR5-CR6R7-; Z represents 0 or S; n is 2, 3,4, 5, 6, 7, 8,9 or 10; m is 2 or 3: A is 0 or S; W is N, C or CH; Q is N, C or CH; the dotted line means an optional bond; R1- R9 are each independently selected from hydrogen, halogen, nitro, cyano, trifluoromethyl, trifluoromethoxy, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-8-cycloalkyl, C3-8-cycloalkyl-C1-6-alkyl, aryl-C1-6-alkyl, C1-6-alkoxy, C1-6-alkylthio, hydroxy, formyl, acyl, amino, C1-6-alkylamino, di(C1-6-alkyl)amino, acylamino, C1-6-alkoxycarbonylamino, aminocarbonylamino, C1-6alkylaminocarbonylamino, and di(C1-6 alkyl)aminocarbonylamino; R10 and R11 are each independently selected from hydrogen and C1-6-alkyl or may together form a bridge consisting of two or three methylene groups; and R12, R13, R14 and R15 are each independently selected from hydrogen, halogen, nitro, cyano, trifluromethyl, trifluoromethoxy, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynl, C3-8-cycloalkyl, C3-8-cycloalkyl-C1-6-alkyl, aryl, heteroaryl, C1-6-alkoxy, C1-6-alkylthio, C1-6-alkylsulphonyl, hydroxyl, formyl, acyl, amino, acylamino, aminocarbonyl, C1-6-alkylaminocarbonylamino, di(C-1-6----alkyl)aminocarbonylamino, SO2NR20R21 and NR20R21. Disclosed is the use of the compound for the treatment of a disorder or disease responsive to the combined effect of inhibition of serotonin uptake and antagonism of 5-HT1A receptors, these include depression, anxiety disorder, and psychosis.
Patent NZ-530479-A (NZ)
Title: Photoactive coating, coated article, and method of making same
Inventor: JOHNSON CHRISTOPHER
IPC: C03C17/25
Filed: 2002-07-12
Abstract: A method of forming a photoactive coating, comprising the step of: depositing a precursor composition by chemical vapor deposition over at least a portion of a float glass ribbon in a molten metal bath, the precursor composition comprising: a photoactive coating precursor material; and at least one other precursor material comprising a dopant that increases photoactivity of the photoactive coating over that of the photoactive coating without the dopant is disclosed. The precursor composition includes a titania precursor material and at least one other precursor material having a metal selected from boron, strontium, zirconium, lead, barium, calcium, hafnium, lanthanum, and mixtures thereof. Sufficient other precursor material is added to the composition such that a molar ratio of the selected metal to titanium in the applied photocatalytic coating is in the range of about 0.001 to about 0.05.
Patent NZ-532523-A (NZ)
Title: Quinazoline derivatives as antitumor agents
Inventor: HENNEQUIN LAURENT FRANCOIS AND
IPC: C07D409/12
Filed: 2002-10-31
Abstract: Disclosed are quinazoline derivatives of Formula I in which its substituents are as described in the specification; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.
Patent NZ-533777-A (NZ)
Title: Controlling cracks in cementitious materials
Inventor: COOK CHRISTOPHER JOHN FEATHERG
IPC: E04B1/68
Filed: 2004-06-25
Abstract: The concrete crack controller (1) is disclosed which comprises of an elongated section having a base (2) with two elongated side walls (3) and (4) angling upwards from the base and joining at the apex forming a hollow section which is generally triangular in a transverse cross section. The base (1) extends slightly from either side of the walls (3) and (4) and the apex of the walls has a vertical extension (6). In use the crack controller is positioned base down such that a cementitious substance prone to cracking can be poured around it and at least partially through it such that cracks which subsequently form within the cementitious substance will occur at or in the vicinity of the crack controller. The concrete or the cementitious substance at least covers the controller (1) and passes through a series of elongated apertures (5) in the side walls (3) and (4).
Patent NZ-536501-A (NZ)
Title: Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Inventor: HOWLEY PAUL
IPC: A61K39/00
Filed: 2003-05-14
Abstract: A recombinant Modified Vaccinia Ankara Virus (MVA) comprises a heterologous DNA sequence inserted into an intergenic region (IGR) of the viral genome. Also described is the use of the MVA for the preparation of a medicament and/or vaccine in the treatment and/or prophylaxis of a viral infection and/or proliferating disease, for example dengue virus infection or immunodeficiency virus infection, preferably HIV infection.
Patent NZ-536899-A (NZ)
Title: Vectors having both isoforms of beta-hexosaminidase
Inventor: KYRKANIDES STEPHANOS
IPC: A01K67/027
Filed: 2003-05-02
Abstract: Disclosed are compositions and methods related to nucleic acid constructs containing a HexB encoding element and a HexA encoding element. These constructs can be used in the treatment of Tray-Sachs and Sandoff disease.
Patent NZ-547695-A (NZ)
Title: Antibodies to OPGL
Inventor: BOYLE WILLIAM J
IPC: C07K16/24
Filed: 2002-06-25
Abstract: Disclosed is an isolated polynucleotide comprising: a) a first nucleic acid sequence that encodes a heavy chain comprising: 1) an amino acid sequence a set forth in SEQ ID NO: 2; or 2) an amino acid sequence as set forth in SEQ ID NO: 13; or 3) an amino acid sequence comprising at least one CDR of SEQ ID NO: 13; and b) a second nucleic acid sequence that encodes a light chain comprising: 1) an amino acid sequence as set forth in SEQ ID NO: 4; or 2) an amino acid sequence as set forth in SEQ ID NO: 14; or 3) an amino acid sequence comprising at least one of CDR1 and CDR3 of SEQ ID NO: 14; and wherein an antibody comprising the heavy chain and the light chain interacts with a human osteoprotegerin ligand (OPGL).
Patent NZ-552418-A (NZ)
Title: Wall mounting bracket with a projecting portion that engages with a storage container
Inventor: STORR JOHN
Filed: 2006-12-22
Abstract: An elongate bracket for attaching to a support surface is disclosed. The bracket 1 comprises a substantially vertical support surface mounting portion 2 for mounting to a support surface 3 via at least one mounting means. A first angled portion extends from a substantially horizontal top edge of the support surface mounting portion. A second angled portion extends from a substantially horizontal bottom edge of the support mounting surface. A projecting portion 5 extends from a substantially horizontal edge of the first angled portion. A bracing portion 7 extends from a substantially horizontal edge of the second angled portion such that the bracing portion contacts the support surface. The projecting portion engages with a complimentary retaining portion on at least one storage container, where the storage container is stabilised by contacting at least one of the first angle portion, support surface mounting portion, second angle portion, or bracing portion at a second point on the storage container. The storage container may be engaged with the projecting portion via the container's complimentary retaining portion at any position along the length of the elongate bracket.
Patent NZ-560402-A (NZ)
Title: Imidazo (1,2-A) pyridine compounds as VEGF-R2 inhibitors
Inventor: BARDA DAVID ANTHONY
IPC: A61K31/4375
Filed: 2006-02-23
Abstract: Disclosed is the compound 2-{2-fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridine-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide or pharmaceutically acceptable salts thereof. Disclosed is the use of the above compound in the manufacture of a medicament to block angiogenesis or treat susceptible neoplasms.